files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346
About US
Editors
Issues
Pages
Indexed in

Research Journal of Medical Sciences, Volume 17, Issue 6 (2023)

References

  1. NCCN., 2016. NCCN clinical practice guidelines in oncology. Ovarian cancer including fallopian tube cancer and primary peritoneal cancer, version 1.2016. Fort Washington, PA: National Comprehensive Cancer Network; 2017..
  2. Nick, A.M., R.L. Coleman, P.T. Ramirez and A.K. Sood, 2015. A framework for a personalized surgical approach to ovarian cancer. Nat. Rev. Clin. Oncol., 12: 239-245.
  3. Chang, S.J. and R.E. Bristow, 2012. Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining ‘optimal’ residual disease. Gynecol. Oncol., 125: 483-492.
  4. Matsuo, K., A.K. Sood and D.M. Gershenson, 2015. Management of Early-stage Ovarian Cancer. In: Surgery for Ovarian Cancer., Bristow, R.E., B.Y. Karlan and D.S. Chi, (Eds.)., CRC Press, Boca Raton, Florida, United States, pp: 67-104.
  5. Prat, J., FIGO-CGO., 2014. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int. J. Gynaecol. Obstet., 124: 1-5.
  6. Chan, J.K., K. Fuh, J.Y. Shin, M.K. Cheung and C.B. Powell et al., 2008. The treatment and outcomes of early-stage epithelial ovarian cancer: Have we made any progress? Br. J. Cancer, 98: 1191-1196.
  7. Rouzier, R., C. Bergzoll, J.L. Brun, G. Dubernard and F. Selle et al., 2010. The role of lymph node resection in ovarian cancer: Analysis of the surveillance, epidemiology, and end results (seer) database. BJOG: Int. J. Obstet. Gynaecol., 117: 1451-1458.
  8. NCI., 2017. ICD-O-3 Coding Materials. Bethesda, MD: National Cancer Institute. https://seer.cancer.gov/icd-o-3/.
  9. Matsuo, K., H. Machida, R.L. Stone, P.T. Soliman, P.H. Thaker, L.D. Roman and J.D. Wright, 2017. Risk of subsequent ovarian cancer after ovarian conservation in young women with stage i endometrioid endometrial cancer. Obstet. Gynecol., 130: 403-410.
  10. Matsuo, K., H. Machida, M.P. Horowitz, M.M.K. Shahzad, S.R. Guntupalli, L.D. Roman and J.D. Wright, 2017. Risk of metachronous ovarian cancer after ovarian conservation in young women with stage i cervical cancer. Am. J. Obstet. Gynecol., 217: 5800-2147483647.
  11. Whitney, C.W. and N. Spirtos, 2009. Gynecologic oncology group surgical procedures manual. Philadelphia, PA: Gynecologic Oncology Group..
  12. Vaughan, S., J.I. Coward, R.C. Bast, A. Berchuck and J.S. Berek et al., 2011. Rethinking ovarian cancer: Recommendations for improving outcomes. Nat. Rev. Cancer, 11: 719-725.
  13. Oliver, K.E., W.E. Brady, M. Birrer, D.M. Gershenson and G. Fleming et al., 2017. An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An nrg oncology/gynecologic oncology group experience. Gynecol. Oncol., 147: 243-249.
  14. Matsuo, K., K. Hasegawa, K. Yoshino, R. Murakami and T. Hisamatsu et al., 2015. Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma. Eur. J. Cancer, 51: 1978-1988.
  15. Nugawela, D. and K.L. Gorringe, 2023. Targeted therapy for mucinous ovarian carcinoma: Evidence from clinical trials. Int. J. Gynecol. Cancer, 33: 102-108.
  16. Schiavone, M.B., T.J. Herzog, S.N. Lewin, I. Deutsch, X. Sun, W.M. Burke and J.D. Wright, 2011. Natural history and outcome of mucinous carcinoma of the ovary. Am. J. Obstet. Gynecol., 205: 261-268.
  17. Kleppe, M., M.A.V. Aa, T.V. Gorp, B.F.M. Slangen and R.F.P.M. Kruitwagen, 2016. The impact of lymph node dissection and adjuvant chemotherapy on survival: A nationwide cohort study of patients with clinical early-stage ovarian cancer. Eur. J. Cancer, 66: 83-90.
  18. Matsuo, K., H. Machida, A. Mariani, R.S. Mandelbaum and G.E. Glaser et al., 2018. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer. J. Gynecol. Oncol., Vol. 29, 5. 10.3802/jgo.2018.29.e69.
  19. Bakkum-Gamez, J.N., A. Mariani, S.C. Dowdy, A.L. Weaver and M.E. McGree et al., 2011. The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. Gynecol. Oncol., 123: 58-64.
  20. Kleppe, M., T. Wang, T.V. Gorp, B.F.M. Slangen, A.J. Kruse and R.F.P.M. Kruitwagen, 2011. Lymph node metastasis in stages i and ii ovarian cancer: A review. Gynecol. Oncol., 123: 610-614.
  21. Creasman, W.T., S. Ali, D.G. Mutch, R.J. Zaino and M.A. Powell et al., 2017. Surgical-pathological findings in type 1 and 2 endometrial cancer: An nrg oncology/gynecologic oncology group study on gog-210 protocol. Gynecol. Oncol., 145: 519-525.
  22. Chan, J.K., R. Urban, M.K. Cheung, J.Y. Shin and A. Husain et al., 2007. Lymphadenectomy in endometrioid uterine cancer staging. Cancer, 109: 2454-2460.